Meeting
2011 ASCO Annual Meeting
The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer (CC) patients using ColoPrint.
Authors
R. Salazar
Institut Catala d'Oncologia, Barcelona, Spain
R. Salazar , R. Rosenberg , M. Lutke Holzik , J. Marshall , J. J. M. Van Der Hoeven , B. Glimelius , F. Bibeau , L. Stork-Sloots , R. A. Bender , J. Capdevila
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session
Track
Special Sessions,Clinical Trials
Sub Track
Colorectal Cancer
Clinical Trial Registration Number
NCT00903565
Citation
J Clin Oncol 29: 2011 (suppl; abstr TPS167)
Abstract #
TPS167
Poster Bd #
44E
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer patients using ColoPrint.
First Author: Ramon Salazar
Poster
2012 Gastrointestinal Cancers Symposium
The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer (CC) patients using ColoPrint.
First Author: Ramon Salazar
Poster
2011 Gastrointestinal Cancers Symposium
The PARSC trial: A prospective study for the assessment of recurrence risk in stage II colon cancer (CC) patients using ColoPrint.
First Author: Ramon Salazar
Poster
2014 ASCO Annual Meeting
Comparison of ColoPrint risk classification with clinical risk in the prospective PARSC trial.
First Author: Ramon Salazar